Insiders · Profile

Thomas John Charles

EVP, General Counsel at Krystal Biotech. Filing since 26 May 2026. CIK 0002114900

Company
Date
Role
Action
Shares
Amount
Of holding
25 Jun 2026
EVP, General Counsel
Sold on a plan
1,000
$347.27K
100%
26 May 2026
EVP, General Counsel
Sold on a plan
642
$193.90K
100%
2 decisions on file.